ACCESSION: MSBNK-SMB_Measured-HSA001P0137000
RECORD_TITLE: Annotated; Hypoxanthine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 40
COMMENT: RAW_SPEC {'5_posi_4078': {'bp': 3100335.0, 'sum': 3268908.0}, '18_posi_4163': {'bp': 3017468.0, 'sum': 3205807.0}, '4_posi_4076': {'bp': 2904493.0, 'sum': 3059076.0}, '12_posi_4098': {'bp': 2874741.0, 'sum': 3010936.0}, '10_posi_4098': {'bp': 2802372.0, 'sum': 2944440.0}, '3_posi_4078': {'bp': 2702975.0, 'sum': 2851351.0}, '9_posi_4098': {'bp': 2697657.0, 'sum': 2867397.0}, '11_posi_4098': {'bp': 2611839.0, 'sum': 2780286.0}, '16_posi_4140': {'bp': 2592134.0, 'sum': 2729019.0}, '19_posi_4223': {'bp': 2564162.0, 'sum': 2731264.0}, '2_posi_4055': {'bp': 2533128.0, 'sum': 2676457.0}, '8_posi_4078': {'bp': 2456394.0, 'sum': 2588502.0}, '15_posi_4121': {'bp': 2381726.0, 'sum': 2528053.0}, '13_posi_4099': {'bp': 2219334.0, 'sum': 2367266.0}, '17_posi_4160': {'bp': 1823518.0, 'sum': 1942854.0}, '7_posi_4100': {'bp': 1674398.0, 'sum': 1798245.0}, '14_posi_4138': {'bp': 1585525.0, 'sum': 1698261.0}, '14_posi_4067': {'bp': 1169624.0, 'sum': 1287217.0}, '17_posi_4086': {'bp': 1100201.0, 'sum': 1198754.0}, '1_posi_4081': {'bp': 1045258.0, 'sum': 1140493.0}, '6_posi_4044': {'bp': 1042996.0, 'sum': 1160547.0}, '6_posi_4119': {'bp': 1020630.0, 'sum': 1144451.0}, '19_posi_4151': {'bp': 984373.0, 'sum': 1061205.0}, '1_posi_4002': {'bp': 876026.0, 'sum': 955815.0}, '11_posi_4042': {'bp': 871457.0, 'sum': 949949.0}, '15_posi_4064': {'bp': 858707.0, 'sum': 955110.0}, '9_posi_4042': {'bp': 827427.0, 'sum': 908873.0}, '16_posi_4068': {'bp': 788798.0, 'sum': 871642.0}, '4_posi_4021': {'bp': 755685.0, 'sum': 854044.0}, '18_posi_4106': {'bp': 692399.0, 'sum': 779358.0}, '12_posi_4043': {'bp': 674896.0, 'sum': 767686.0}, '3_posi_4020': {'bp': 622630.0, 'sum': 688831.0}, '10_posi_4040': {'bp': 582300.0, 'sum': 675245.0}, '5_posi_4020': {'bp': 559163.0, 'sum': 650038.0}, '13_posi_4043': {'bp': 520136.0, 'sum': 603097.0}, '2_posi_4001': {'bp': 484643.0, 'sum': 566204.0}, '7_posi_4025': {'bp': 420834.0, 'sum': 512547.0}, '8_posi_4022': {'bp': 356440.0, 'sum': 453956.0}, '8_posi_4147': {'bp': 353073.0, 'sum': 458324.0}, '5_posi_4149': {'bp': 159107.0, 'sum': 242158.0}}
COMMENT: RETENTION_TIME_STDEV 0.101
COMMENT: PRECURSOR_M/Z_RAW 137.045471
COMMENT: PRECURSOR_M/Z_STDEV 0.000045
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.088; C5H4N4O; [M+H]+; delta(ppm) 0.088210
COMMENT: PROPOSED_MF MS-FINDER 4.066; C5H4N4O; [M+H]+; delta(ppm) 0.086022
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.758; C4H8O5; [M+H]+; delta(ppm) 9.845002
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.657; C5H4N4O; [M+H]+; delta(ppm) 0.086022
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.819; C5H12S2; [M+H]+; delta(ppm) 3.503843
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.517; C4H8O5; [M+H]+; delta(ppm) 9.845002
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.483; C5H4N4O; [M+H]+; delta(ppm) 0.086022
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.911; C5H4N4O; [M+H]+; delta(ppm) 0.086022
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.147; C4H8O5; [M+H]+; delta(ppm) 9.845002
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.778; C4H9ClN2O; [M+H]+; delta(ppm) -149035.538370
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.265; C3H9N2O2P; [M+H]+; delta(ppm) -11.966497
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.597; C7H6NO2; [M+H]+; delta(ppm) -9.711073
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.827; C2H5FN4O2; [M+H]+; delta(ppm) -8.251662
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.181; C5H12S2; [M+H]+; delta(ppm) 3.503843
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.472; C5H5F3N; [M+H]+; delta(ppm) 8.131663
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.030; C2H7ClN5; [M+H]+; delta(ppm) -149028.443769
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.073; C3H2N7; [M+H]+; delta(ppm) 9.883308
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.948; C5H4N4O; [M+H]+; delta(ppm) 0.086022
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.023; C4H8O5; [M+H]+; delta(ppm) 9.845002
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.014; C3H9N2O2P; [M+H]+; delta(ppm) -11.966497
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.012; C4H9ClN2O; [M+H]+; delta(ppm) -149035.538370
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C7H6NO2; [M+H]+; delta(ppm) -9.711073
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C2H5FN4O2; [M+H]+; delta(ppm) -8.251662
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 31.000; FDGQSTZJBFJUBT-UHFFFAOYSA-N; C5H4N4O; Spectral Match to Hypoxanthine from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 20.000; OFCNXPDARWKPPY-UHFFFAOYSA-N; C5H4N4O; Massbank:EQ333601 Allopurinol1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 4.000; JFZSDNLQDTYVEE-UHFFFAOYSA-N; C5H4N4O; Massbank:FIO00455 Allopurinol
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.583; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; O=C1N=CNC2=C1NN=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.235; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; OC1=NC=NC2=C1NC=N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.212; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; OC=1N=CC2=NCN=C2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.125; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; O=C1N=CN=C2NNC=C12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.917; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; OC1=NC=NC2=C1N=NC2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.893; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.306; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; Allopurinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.062; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; CNP0440561
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.003; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.993; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.993; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M+H]+; CNP0439982
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.923; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M+H]+; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.923; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.889; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.837; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.785; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M+H]+; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.990; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.942; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.931; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.906; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M+H]+; CNP0439982
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.894; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; Allopurinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.883; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.883; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.883; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.877; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; CNP0440561
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.874; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.393; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; 1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.908; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3-hydroxytriazolo[4,5-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; QBKYWNHLILCGEI-UHFFFAOYSA-N; [M+H]+; 4-cyano-1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 3,7-dihydropurin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; DHQDPICNDWFEBQ-UHFFFAOYSA-N; [M+H]+; 5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; QICFIUZWDPJRQF-UHFFFAOYSA-N; [M+H]+; 1,6-dihydropyrazolo[3,4-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; DSZCQHJBMSIMNX-UHFFFAOYSA-N; [M+H]+; 3,6-dihydroimidazo[4,5-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; RBWFEMOYMLQPAV-UHFFFAOYSA-N; [M+H]+; 1,5-dihydropyrazolo[3,4-d]pyridazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; JDPCCIANHKTFII-UHFFFAOYSA-N; [M+H]+; 6H-[1,2,4]triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; VNMKCHFGAZFWKI-UHFFFAOYSA-N; [M+H]+; 6H-[1,2,4]triazolo[4,3-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; CLGWVBPVZYVPMR-UHFFFAOYSA-N; [M+H]+; 2H-[1,2,4]triazolo[4,3-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; GLVYFVYELPFNQC-UHFFFAOYSA-N; [M+H]+; 6H-pyrazolo[5,1-c][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; GXBDCPYXMVITMR-UHFFFAOYSA-N; [M+H]+; 1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; RDHMBEKEDDDWOF-UHFFFAOYSA-N; [M+H]+; 4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; QMFPURRPZZSJPF-UHFFFAOYSA-N; [M+H]+; 3H-imidazo[2,1-f][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; REINGZOTPYBONL-UHFFFAOYSA-N; [M+H]+; [1,2]oxazolo[5,4-d]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; GJDZQWVZICYPIT-UHFFFAOYSA-N; [M+H]+; [1,3]oxazolo[5,4-d]pyrimidin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; WKOSBXIJGCIJII-UHFFFAOYSA-N; [M+H]+; [1,2]oxazolo[4,5-b]pyrazin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -34.604; FDGQSTZJBFJUBT; [M+H]+; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -38.127; JFZSDNLQDTYVEE; [M+H]+; Zyloprim (TN)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -60.191; CRIZPXKICGBNKG; [M+H]+; 2-Purinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -65.898; YPDSIEMYVQERLJ; [M+H]+; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -79.325; JDPCCIANHKTFII; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.358; OFCNXPDARWKPPY; [M+H]+; Ailurial
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.101; DHQDPICNDWFEBQ; [M+H]+; AmbscX-046497
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.714; NYNNJBKGLLSTAZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.019; GXBDCPYXMVITMR; [M+H]+; [1,2,4]Triazolo[1,5-a]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.061; OGCXIHWGXUQTCQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.124; CYYQSLSRZGVVHE; [M+H]+; Purine 3-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.784; FPIRBHDGWMWJEP; [M+H]+; 1-Hydroxy-7-azabenzotriazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.477; QBKYWNHLILCGEI; [M+H]+; ACMC-20amkb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.723; AXEBUIBRUVSSHM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.347; FDGQSTZJBFJUBT; [M+H]+; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -23.168; FDGQSTZJBFJUBT; [M+H]+; Sarkin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.298; CRIZPXKICGBNKG; [M+H]+; 7H-purin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.033; JFZSDNLQDTYVEE; [M+H]+; 7-Hydroxypyrazolo[4,3-d]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -79.552; QICFIUZWDPJRQF; [M+H]+; 1,6-Dihydropyrazolo[3,4-d]pyridazin-2-ium-7-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -94.236; YPDSIEMYVQERLJ; [M+H]+; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -94.307; RBWFEMOYMLQPAV; [M+H]+; 1,5-Dihydropyrazolo[3,4-d]pyridazin-2-ium-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.605; DHQDPICNDWFEBQ; [M+H]+; Pyrazolo[1,5-d][1,2,4]triazin-4(5H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.041; NYNNJBKGLLSTAZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.985; JDPCCIANHKTFII; [M+H]+; 6H-[1,2,4]Triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.207; VHJRRKBEQDXLHP; [M+H]+; 9H-Purine-9-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.871; FDGQSTZJBFJUBT; [M+H]+; Sarkin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Hypoxanthine, FDGQSTZJBFJUBT-UHFFFAOYSA-N; Matching to 31 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (7), MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0000157;
CH$NAME: Hypoxanthine
CH$NAME: 3,7-dihydropurin-6-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H4N4O
CH$EXACT_MASS: 136.038511
CH$SMILES: C1=NC2=C(N1)C(=O)N=CN2
CH$IUPAC: InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)
CH$LINK: CHEBI CHEBI:17368
CH$LINK: HMDB HMDB0000157
CH$LINK: INCHIKEY FDGQSTZJBFJUBT-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:790
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 8.180
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 137.045799
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-0900000000-2a389cb573c15e1330a9
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  94.0399129 7.7466 94.040280 2.2437 1.81 0.9173 37 f{C4H4N3}/-0.64ppm,p-C1H1N1O1
  110.0348631 12.2309 110.035090 1.0633 2.44 0.9555 39 f{C4H4N3O1}/-0.23ppm,p-C1H1N1
  119.0352479 10.2707 119.035370 1.5542 2.17 0.9388 37 f{C5H3N4}/0.21ppm,p-H2O1
  137.0458138 999.0000 137.045720 0.3357 0.00 1.0000 40 f{C5H5N4O1}/0.19ppm,p
  137.1071288 14.5177 137.107035 2.8883 13.73 0.0607 34 ?
PK$NUM_PEAK: 5
PK$PEAK: m/z int. rel.int.
  94.039913 7.75 7
  110.034863 12.23 12
  119.035248 10.27 10
  137.045814 999.00 999
  137.107129 14.52 14
//
